Dokoupil, Tony. (2007, July). Trouble in a 'Black Box'; Did an effort to reduce teen suicides backfire :[U.S. Edition]. Newsweek, 150(3), 48. Retrieved February 25, 2008, from Research Library database. (Document ID: 1302292331).
Tony Dokoupil’s Trouble in a 'Black Box'; Did an effort to reduce teen suicides backfire, the FDA is under fire. Dokoupil gives firsthand accounts from some of those who were doing the voting for the “black box” and some of those doctors and parents that oppose it. He also interestingly enough, states that when the label first appeared they were praised for their care and understanding for their patients. But that quickly changed when the new numbers of suicide rates were presented by the CDC. The voters argument is that the warning was never meant to discourage use of the drug, rather, to inform the patient of all possible risks. Those who oppose say that is was to discourage and it did so dramatically; the SSRI sales dropped almost 50% in 2003-2005. The argument that it saves more lives than kills is big among them. The only discouraging thing to those people is that the FDA has only repealed one “black box” in history. Only another year of high suicides rates will be able to help those who want the label gone.
Sunday, April 13, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment